Researchers show that using continuous glucose monitors can help measure glucose accurately during DKA and potentially prevent ICUs from being overwhelmed. Diabetic ketoacidosis is a common severe ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Alternative, patient-tailored strategies are needed to ...

Please provide your email address to receive an email when new articles are posted on . Patients with mild to moderate diabetic ketoacidosis admitted to the ED may be successfully treated with ...

At the beginning of every year, I try to consider what I can do better when it comes to managing my patients with diabetes. This year, I've decided I need to be better at prescribing both glucagon and ...

Expert Rev Endocrinol Metab. 2012;7(4):433-443. It is not recommended to stop an already initiated insulin infusion, but rather to introduce dextrose infusion with a 'two-bag system' if the blood ...

Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can't produce enough insulin. During DKA the body starts breaking down fat, causing a buildup of acids ...

Sodium is the primary cation. Chloride and bicarbonate are the primary anions. The anion gap is the numeric result of subtracting the sums of the chloride and bicarbonate concentrations from that of ...

Diabetic ketoacidosis (DKA) is the leading cause of death, morbidity and excessive health-care utilization and costs in patients with type 1 diabetes mellitus; DKA is common at initial diagnosis, but ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with an almost 3-fold increased risk of diabetic ketoacidosis (DKA) in some patients with type 2 diabetes (T2D), according to data from ...

Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can’t produce enough insulin. During DKA the body starts breaking down fat, causing a buildup of acids ...

To develop DKA, the patient must experience a relative insulin deficiency 4 (very little circulating insulin) in the setting of increased counter-regulatory hormone concentrations. This relative lack ...